Results 251 to 260 of about 978,977 (295)
Some of the next articles are maybe not open access.
Bone Morphogenetic Protein and Fusion
Journal of Neurosurgery: Spine, 2007In their article (Villavicencio AT, Burneikiene S, Nelson EL, et al: Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein– 2. J Neurosurg Spine 3: 436– 443, December, 2005), Villavicencio and colleagues referred to the work by Haid et al., claiming that the fusion rates during ...
Pećina, Marko +2 more
openaire +2 more sources
2016
Albumin fusion technology can improve the blood retention properties of protein-based pharmaceutics that have a short circulation half-life. The procedure consists of fusing the HSA gene with the gene for a therapeutic protein or peptide, thus permitting the existing recombinant protein therapeutics to be reengineered using albumin as a suitable and ...
Toru Maruyama +2 more
openaire +1 more source
Albumin fusion technology can improve the blood retention properties of protein-based pharmaceutics that have a short circulation half-life. The procedure consists of fusing the HSA gene with the gene for a therapeutic protein or peptide, thus permitting the existing recombinant protein therapeutics to be reengineered using albumin as a suitable and ...
Toru Maruyama +2 more
openaire +1 more source
2018
IgG-based therapeutics has become an increasingly important category of the over two hundred biopharmaceutical products approved in the USA and the EU by late 2014. While a large percentage of this consists of monoclonal antibodies, Fc fusion proteins make up an important class of IgG-based biotechnology drugs.
Carole Heath, Dean Pettit
openaire +1 more source
IgG-based therapeutics has become an increasingly important category of the over two hundred biopharmaceutical products approved in the USA and the EU by late 2014. While a large percentage of this consists of monoclonal antibodies, Fc fusion proteins make up an important class of IgG-based biotechnology drugs.
Carole Heath, Dean Pettit
openaire +1 more source
Quantitative lmmunoblotting with Fusion Proteins
2003The development of vaccines against HIV-1 is currently hindered by incomplete understanding of correlates of protective immunity (1-3). Experiments are necessary to measure immune responses in sufficiently fine detail that specific protective responses can be discerned from those that are irrelevant or harmful.
M M, Mitchell, L D, Loomis-Price
openaire +2 more sources
Mechanisms of SNARE proteins in membrane fusion
Nature Reviews Molecular Cell Biology, 2023Reinhard Jahn, Lukas K Tamm
exaly
Virus membrane-fusion proteins: more than one way to make a hairpin
Nature Reviews Microbiology, 2006Margaret Kielian, Félix A Rey
exaly
Mechanisms of membrane fusion: disparate players and common principles
Nature Reviews Molecular Cell Biology, 2008Sascha Martens, Harvey T Mcmahon
exaly